Biden invokes Defense Production Act to boost baby formula manufacturing to ease shortage

The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022.

Jeff Kowalsky | AFP | Getty Images

President Joe Biden on Wednesday invoked the Defense Production Act to increase baby formula manufacturing to ease a nationwide shortage caused by the closure of a key plant in Michigan.

Biden is requiring suppliers to direct goods used to make baby formula to key formula manufacturers before any other customers who may have placed orders for those same items.

The president has also directed the Health and Human Services Department and Department of Agriculture to use aircraft from the Defense Department to pick up infant formula from overseas that meets U.S. health and safety standards.

Parents across the nation have struggled to find formula for their infants since Abbott Nutrition shuttered its plant in Sturgis, Michigan due to bacterial contamination. Abbott issued a recall in February of powdered formula brands made at the plant after four infants who consumed products made there fell ill with bacterial infections, two of whom died.

The Justice Department, in a complaint filed Monday, said Abbott had introduced adulterated baby formula into the consumer market. Abbott maintains that there’s “no conclusive evidence” that its formula caused the infants to fall ill.

Abbott reached an agreement with the Food and Drug Administration on Monday to reopen the plant under certain conditions subject to enforcement by a federal court. However, Abbott has said it would take about two weeks to reopen the Michigan facility, subject to FDA approval, and up to eight weeks for products to arrive in stories across the country.

The U.S. produces 98% of the baby formula American parents buy and four manufacturers – Abbott, Mead Johnson Nutrition, Nestle USA and Perrigo – dominate the market. When one plant goes offline, the supply chain is easily disrupted.

The FDA is increasing baby formula imports from other countries to help ease the shortage. To sell formula in the U.S., companies have to submit an application to the FDA, which the agency will review to make sure its safe and provides adequate nutrition.

However, Democratic lawmakers said this week that the FDA does not have nearly enough inspectors to ensure imported formula is safe. Rep. Rosa DeLauro, chair of the House Appropriations Committee, said the FDA told her it has only nine inspectors to keep an eye on infant formula manufacturers.

DeLauro introduced legislation this week that would provide the FDA with $28 million in emergency funding to beef up inspections, more closely monitor the supply chain and root out fraud.

This is breaking news. Please check back for updates.

For all the latest health News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.